Although some studies have shown that the expression of CNR2 was increased in the frontal cortex of patients with AD [23, 29], few studies have focused on the precuneus, the brain region where Aβ accumulation preferentially starts in preclinical AD. The gene discussed is CNR2; the disease is Alzheimer disease.